Literature DB >> 19024988

The effect of vitamin E on basic fibroblast growth factor level in human fibroblast cell culture.

S A Harun Nor Rashid1, A S Halim, N A Muhammad.   

Abstract

Basic fibroblast growth factor (bFGF) is angiogenic and effective in down-regulating excess collagen production. The aim of this study is to evaluate the effectiveness of vitamin E (Tocotrienol Rich Fraction) in altering the level of bFGF, a cytokine involved in the scar formation process. In this model, normal human fibroblasts were treated with various concentrations of vitamin E at different time frames. The levels of bFGF were determined by Enzyme-Linked Immunosorbant Assay (ELISA). This study demonstrated that Tocotrienol Rich Fraction (TRF) stimulated bFGF production by fibroblast and postulate that vitamin E may decrease aberrant scar formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19024988

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

Review 1.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

2.  Fat Grafts Augmented With Vitamin E Improve Volume Retention and Radiation-Induced Fibrosis.

Authors:  Darren B Abbas; Christopher V Lavin; Evan J Fahy; Michelle Griffin; Nicholas J Guardino; Rahim S Nazerali; Dung H Nguyen; Arash Momeni; Michael T Longaker; Derrick C Wan
Journal:  Aesthet Surg J       Date:  2022-08-01       Impact factor: 4.485

Review 3.  Pharmacological potential of tocotrienols: a review.

Authors:  Haseeb Ahsan; Amjid Ahad; Jahangir Iqbal; Waseem A Siddiqui
Journal:  Nutr Metab (Lond)       Date:  2014-11-12       Impact factor: 4.169

4.  Comparison between tocotrienol and omeprazole on gastric growth factors in stress-exposed rats.

Authors:  Mohd Fahami Nur Azlina; Hj Mohd Saad Qodriyah; Kien Hui Chua; Yusof Kamisah
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.